-
Product Insights
NewLikelihood of Approval Analysis for Female Hypoactive Sexual Desire Disorder
Overview How likely is it that the drugs in Female Hypoactive Sexual Desire Disorder will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Female Hypoactive Sexual Desire Disorder Overview Hypoactive sexual desire...
-
Product Insights
Female Hypoactive Sexual Desire Disorder – Drugs In Development, 2023
Global Markets Direct’s, ‘Female Hypoactive Sexual Desire Disorder - Drugs In Development, 2023’, provides an overview of the Female Hypoactive Sexual Desire Disorder pipeline landscape. The report provides comprehensive information on the therapeutics under development for Female Hypoactive Sexual Desire Disorder, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest...
-
Product Insights
NewLikelihood of Approval Analysis for Pruritus
Overview How likely is it that the drugs in Pruritus will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pruritus Overview Pruritus, or itch, is defined as an unpleasant sensation that provokes...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Flibanserin in Male Hypoactive Sexual Desire Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Flibanserin in Male Hypoactive Sexual Desire Disorder report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Flibanserin in Male Hypoactive Sexual Desire Disorder Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Testosterone in Female Hypoactive Sexual Desire Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Testosterone in Female Hypoactive Sexual Desire Disorder report and make more profitable business decisions. How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sildenafil Citrate in Female Hypoactive Sexual Desire Disorder
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sildenafil Citrate in Female Hypoactive Sexual Desire Disorder report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sildenafil Citrate in Female Hypoactive Sexual Desire...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Sildenafil Citrate + Testosterone) in Female Hypoactive Sexual Desire Disorder
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Sildenafil Citrate + Testosterone) in Female Hypoactive Sexual Desire Disorder Drug Details: Sildenafil citrate...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Buspirone Hydrochloride + Testosterone) in Female Hypoactive Sexual Desire Disorder
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Buspirone Hydrochloride + Testosterone) in Female Hypoactive Sexual Desire Disorder Drug Details: Buspirone hydrochloride...
-
Sector Analysis
Italy Source Tourism Insight by Domestic and Outbound Tourism, Key Destinations and Tourist Profiles, 2024 Update
Italy Source Tourism Report Overview The total outbound trips in Italy surpassed pre-pandemic levels, increasing to 35.22 million in 2023. The strong desire to travel and experience new things post the easing of pandemic-related travel restrictions; the reduction in travel costs by low-cost airlines; and the growing disposable incomes of younger passengers are contributing to this development. The projected compound annual growth rate (CAGR) for international departures is more than 6% for 2023-2027. The Italy source tourism market research report...
-
Sector Analysis
NewFemale Sexual Dysfunction (FSD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Female Sexual Dysfunction (FSD) Marketed and Pipeline Drugs Report Overview Female sexual dysfunction (FSD) is an umbrella term that encompasses disorders of sexual desire, orgasm, arousal, and sexual pain that result in significant personal distress. FSD is a multifactorial, progressive problem that can occur at any stage of life. It is a complex neurovascular phenomenon that is under the control of psychological, neurovascular, and hormonal factors. Key Mechanisms of Action (Marketed) ·       Receptor Agonist ·       Enzyme Inhibitor ·       Receptor Antagonist...